 BOSTON, July 08, 2021 GLOBE NEWSWIRE -- Ikena Oncology, Inc. Nasdaq: IKNA, a targeted oncology company focused on developing therapies targeting key signaling pathways that drive the formation and spread of cancer, today announced that Dr. Mark Manfredi, CEO of Ikena Oncology, will participate in a panel discussing next-generation approaches to targeted oncology at the upcoming virtual William Blair Biotech Focus Conference. 